Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4658-4661

  Zhao, Jianming ^a   Richter, Jan ^a   Wagner, Urs ^a   Roth, Beat ^a   Schraml, Peter ^a   Zellweger, Tobias ^b   Ackermann, Daniel ^b   Schmid, Ulrico ^b   Moch, Holger ^a   Mihatsch, Michael J ^a   Gasser, Thomas C ^a   Sauter, Guido ^a,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DETERMINATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECURRENCE RISK; Y CHROMOSOME;

CARCINOMA IN SITU; CARCINOMA, PAPILLARY; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DISEASE-FREE SURVIVAL; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; URINARY BLADDER NEOPLASMS;

EID: 0033567926     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wagner, U., Süess, K., Schmid, U., Ackermann, D., Zellweger, T., Maurer, R., Alund, G., Knänagel, H., Rist, M., Jordan, P., Moch, H., Mihatsch, M. J., Gasser, T., and Sauter, G. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer. J. Pathol., 188: 44-50, 1999.
2. Richter, J., Jiang, F., Görög, J., Sartorius, G., Moch, H., Egenter, C., Gasser, T., Mihatsch, M., and Sauter, G. Marked genetic differences between pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57: 2860-2864, 1997.
3. Simon, R., Bürger, H., Brinkschmidt, C., Böcker, W., Hertle, L., and Terpe, H. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J. Pathol., 185: 345-351, 1998.
4. Kallioniemi, A., Kallioniemi, O., Sudar, D., Rutovitz, D., Gray, J., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
5. Union International Contre Cancer. UICC TNM Classification of Malignant Tumors, Ed. 4. Berlin: Springer, 1992.
6. Mostofi, F. Histological Typing of Urinary Bladder Tumors, Vol. 10. Geneva: World Health Organization, 1973.
7. Richter, J., Beffa, L., Wagner, U., Schraml, P., Gasser, T., Moch, H., Mihatsch, M., and Sauter, G. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am. J. Pathol., 153: 1615-1621, 1998.
8. Kaplan, E., and Meier, P. Nonparametic estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
9. Kallioniemi, A., Kallioniemi, O., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Carroll, P., and Waldman, F. Identification of novel DNA amplifications and deletions in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12: 213-219, 1995.
10. Ruppert, J., Tokino, T., and Sidransky, D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res., 53: 5093-5095, 1993.
11. Cairns, P., Shaw, M., and Knowles, M. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res., 53: 1230-1232, 1993.
12. Simoneau, A., Spruck, C., Gonzalez, Z., M, Gonzalgo, M., Chan, M., Tsai, Y., Dean, M., Steven, K., Horn, T., and Jones, P. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res., 56: 5039-5043, 1996.
13. Cairns, P., Mao, L., Merlo, A., Lee, D., Schwab, D., Tokino, K., van der Riet, P., Blaugrund, J., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265: 415-416, 1994.
14. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S., Stockert, E., Day, R., III, Johnson, B., and Skolnick, M. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
15. Miyamoto, H., Kubota, Y., Fujinami, K., Dobashi, Y., Kondo, K., Yao, M., Shuin, T., and Hosaka, M. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer. p16 mutations occur only in low-grade and superficial bladder cancers. Oncol. Res., 7: 327-330, 1995.
16. Orlow, I., Lacombe, L., Hannon, G., Serrano, M., Pellicer, I., Dalbagni, G., Reuter, V., Zhang, Z., Beach, D., and Cordon-Cardo, C. Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst., 87: 1524-1529, 1995.
17. Sauter, G., Moch, H., Wagner, U., Novotna, H., Gasser, T., Mattarelli, G., Mihatsch, M., and Waldman, F. Y Chromosome loss detected by FISH in bladder cancer. Cancer Genet. Cytogenet., 82: 163-169, 1995.
18. United Kingdom Cancer Cytogenetics Group. Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer, 5: 83-88, 1992.
19. Isola, J., Kallioniemi, O., Chu, L., Fuqua, A., Hilsenbeck, S., Osborne, C., and Waldman, F. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol., 147: 905-911, 1995.
20. Moch, H., Presti, J., Sauter, G., Buchholz, N., Mihatsch, M., and Waldman, F. Comparative genomic hybridization for detection of DNA copy number abnormalities in renal cell carcinoma. Cancer Res., 56: 27-30, 1996.
21. Sallinen, S., Sallinen, P., Haapasalo, H., Kononen, J., Karhu, R., Helen, P., and Isola, J. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. Am. J. Pathol., 151: 1799-1807, 1997.
22. Gustafson, H., Tribukait, B., and Esposti, P. The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand. J. Urol. Nephrol., 16: 141-146, 1982.
23. Tribukait, B., Gustafson, H., and Esposti, P. The significance of ploidy and proliferation in the clinical evaluation of bladder tumors. Br. J. Urol., 54: 130-135, 1982.
24. Tribukait, B. Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J. Urol., 5: 108-122, 1987.
25. Rosin, M. P., Cairns, P., Epstein, J. I., Schoenberg, M. P., and Sidransky, D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res., 55: 5213-5216, 1995.
26. Neuhaus, M., Wagner, U., Schmid, U., Ackermann, D., Zellweger, T., Maurer, R., Alund, G., Knönagel, H., Rist, M., Moch, H., Mihatsch, M., Gasser, T., and Sauter, G. Polysemies but not Y chromosome losses have prognostic significance in superficial urinary bladder cancer. Hum. Pathol., 30: 81-86, 1999.
27. Dalbagni, G., Presti, J., Reuter, V., Fair, W. R., and Cordon, C. C. Genetic alterations in bladder cancer. Lancet, 342: 469-471, 1993.
28. Spruck, C. H. I., Ohneseit, P. F., Gonzalez, Z. M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G., and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54; 784-788,1994.
29. Esrig, D., Spruck, C. H. I., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A., and Cote, R. J. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
30. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T., and Terada, M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52: 1393-1398, 1992.
31. Vet, J. A., Bringuier, P. P., Karthaus, H. F., Poddighe, P. J., Debruyne, F. M., and Schalken, J. A. p53 mutations have no additional prognostic value over stage in bladder cancer. Br. J. Cancer, 70: 496-500, 1994.